Johnson & Johnson (JNJ) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Johnson & Johnson (JNJ) carries a Roarable Rating of C+ (Hold) with 66/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How JNJ Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $94.19B | 67.9% | 33.6% | $26.80B | $19.70B | 24.7% |
| FY 2024 | $88.82B | 69.1% | 18.7% | $14.07B | $19.84B | 16.8% |
| FY 2023 | $85.16B | 44% | 48.7% | $35.15B | $18.96B | 14.9% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring JNJ)
- ✓Live walkthrough of JNJ's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
JNJ Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on JNJ today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for JNJ. Explore sector supply chains on /butterfly.
JNJ Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Johnson & Johnson (JNJ)?
In FY 2025 (10-K), JNJ converted $94.2B of revenue into a 67.9% gross margin, 33.6% operating margin, and $19.7B in free cash flow (20.9% FCF margin).